The 26-week, international, open-label, phase III trial had 1,663 type 2 diabetic subjects that were insulin-nave and poorly controlled on Metformin with or without pioglitizone
c ch s hnh thnh cc hc sc t melanin gy thm sm
FDA approved for weight management due to its impressive efficacy in promoting weight loss
If we extrapolate that globally, the number could be close to a million people or more, so the public health impact could be considerable. For more information: Colton Frisco Jones, MD, can be reached at [email protected].
Last Published 03.02.2026 Effective Date: 03.01.2026 This policy addresses percutaneous vertebroplasty and kyphoplasty for treating spinal pain
Eli Lilly is planning to submit orforglipron (Foundayo) for the treatment of T2DM in the second quarter of 2026 under the CNPV pilot program, making it possible for the drug to receive FDA approval in late 2026